Schedule 13G ownership disclosure

Madrigal Pharmaceuticals Inc

Security class unavailable · CUSIP: 558868105

Event date: 2023-09-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,042,661
Percent of class
15.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001274173-23-000091
Form type
SC 13G/A
Filer
Janus Henderson Group Ltd.
CIK
CIK 1274173
Filed
Oct 10, 2023
Reporting period
Sep 29, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub